Morgan Stanley Eledon Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.49 Trillion
Q2 2025

A detailed history of Morgan Stanley transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 345,629 shares of ELDN stock, worth $919,373. This represents 0.0% of its overall portfolio holdings.

Number of Shares

345,629

Previous 221,957 55.72%

Holding current value

$919,373

Previous $752,000 24.47%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$2.6 - $3.36 $321,547 - $415,537	123,672 Added 55.72%	345,629 $936,000
Q1 2025 May 15, 2025	BUY	$3.35 - $4.83 $158,960 - $229,188	47,451 Added 27.19%	221,957 $752,000
Q4 2024 Feb 14, 2025	BUY	$2.45 - $5.3 $223,035 - $482,485	91,035 Added 109.06%	174,506 $713,000
Q3 2024 May 14, 2025	BUY	$2.41 - $3.19 $195,971 - $259,398	81,316 Added 3773.36%	83,471 $207,000
Q3 2024 Nov 14, 2024	BUY	$2.41 - $3.19 $195,971 - $259,398	81,316 Added 3773.36%	83,471 $207,000
Q2 2024 May 14, 2025	SELL	$1.57 - $3.12 $270,591 - $537,735	-172,351 Reduced 98.77%	2,155 $5,000
Q2 2023 Aug 14, 2023	BUY	$1.34 - $2.85 $2,887 - $6,141	2,155 New	2,155 $2,000
Q4 2022 Feb 14, 2023	SELL	$2.17 - $2.75 $2,456 - $3,113	-1,132 Reduced 99.91%	1 $0
Q3 2022 Nov 14, 2022	SELL	$2.45 - $3.88 $2,202 - $3,488	-899 Reduced 44.24%	1,133 $3,000
Q2 2022 Oct 27, 2022	BUY	$2.34 - $3.96 $650 - $1,100	278 Added 15.85%	2,032 $5,000
Q2 2022 Aug 15, 2022	BUY	$2.34 - $3.96 $650 - $1,100	278 Added 15.85%	2,032 $5,000
Q1 2022 Oct 27, 2022	SELL	$3.06 - $4.89 $850 - $1,359	-278 Reduced 13.68%	1,754 $7,000
Q1 2022 May 13, 2022	SELL	$3.06 - $4.89 $21,472 - $34,313	-7,017 Reduced 80.0%	1,754 $7,000
Q4 2021 Feb 14, 2022	SELL	$4.02 - $6.07 $404,753 - $611,157	-100,685 Reduced 91.99%	8,771 $39,000
Q3 2021 Nov 15, 2021	BUY	$5.94 - $8.46 $650,168 - $925,997	109,456 New	109,456 $677,000

Others Institutions Holding ELDN

# of Institutions

Shares Held

36.8M

Call Options Held

48.5K

Put Options Held

30.3K

View Full List

About Eledon Pharmaceuticals, Inc.

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $36.6M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

More about ELDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account